The present invention generally pertains to handheld medical, veterinary, and pre-clinical or laboratory research devices, and more specifically to electrically driven lancets, needles, epidural catheter inserters, biopsy instruments, vascular entry instruments, spinal access needles, and other catheterization needles. The invention is applicable to the delivery and removal of blood, tissues, medicine, nutrients, or other materials within the body.
In the fields of medicine, veterinary, and pre-clinical or laboratory research the need to insert penetrating members (such as needles and lancets) into living tissues is ubiquitous. Some of the reasons necessitating tissue penetration and insertion of penetrating members include: to inject medications and vaccines, to obtain samples of bodily fluids such as blood, to acquire a tissue sample such as for biopsy, or to provide short or long term access to the vascular system such as intravenous (IV) catheter placement.
Of the 39 million patients hospitalized in the United States, 31 million (80%) receive an IV catheter for nutrition, medication, and fluids. Obtaining peripheral venous access is complicated by loose tissue, scar tissue from repeat sticks, hypotension, hypovolemic shock, and/or dehydration. These factors manifest in easily collapsed veins, rolling veins, scarred veins, and fragile veins making venipuncture problematic. Most hospitals allow a clinician to make several attempts at peripheral IV access before the hospital “IV team” is called. Studies have shown that success can improve significantly with experience. There are also a number of techniques that can be used such as tourniquets, nitroglycerin ointment, hand/arm warming, but these require additional time, are cumbersome, and do not work effectively in all situations. Tools are also available to improve visualization of the vasculature that use illumination, infrared imaging, or ultrasound. These tools, however, do not simplify peripheral venous access into a collapsible vein. In emergency situations, a clinician will often insert a central venous catheter (CVC) or possibly an intraosseous line. These procedures are more invasive, costly, and higher risk. Multiple needle sticks significantly increase patient anxiety and pain, leading to decreased patient cooperation, vasoconstriction, and greater opportunity for infection and complications. Repeated attempts to obtain venous access are costly to the healthcare facility; estimated at over $200,000 annually for a small hospital. In endoscopy facilities, which see large numbers of older patients, the problem is further exacerbated by fasting requirements that decreases the pressure in the veins. During cannulation, the needle and catheter push the near wall of the vein into the far wall, collapsing the vein—inhibiting the ability to place the needle into the inner lumen of the vein.
Tissue deformation during needle insertion is also an issue for soft tissue biopsy of tumors or lesions. Conventional needles tend to deform the tissue during the insertion, which can cause misalignment of the needle path and the target area to be sampled. The amount of tissue deformation can be partially reduced by increasing the needle insertion velocity, and so this property has been exploited by biopsy guns on the market today.
Blood sampling is one of the more common procedures in biomedical research involving laboratory animals, such as mice and rats. A number of techniques and routes for obtaining blood samples exist. Some routes require/recommend anesthesia (such as jugular or retro-orbital), while others do not (such as tail vein/artery, saphenous vein or submandibular vein). All techniques utilize a sharp (lancet, hypodermic needle, or pointed scalpel) that is manually forced into the tissue to produce a puncture that bleeds. A capillary tube is positioned over the puncture site to collect the blood droplets for analysis, or the blood may be collected into a syringe or vacuum vial. Regardless of the sharp used, if an individual is properly trained the procedure can be performed quickly to minimize pain and stress. It is important to minimize stress as this can interfere with blood chemistry analysis, particularly for stress-related hormones. Another much more expensive strategy is to place an indwelling catheter and obtain blood samples in an automated device. However, the catheter cannot be left in over the life span. In addition, the tethering jackets and cables, which must remain in contact with the animal, will likely cause stress. Microneedles can be implanted with highly reduced insertion force and less pain, but may not produce a large enough puncture to yield significant blood for collection and analysis.
Research supports that needle vibration, or oscillation, causes a reduction in needle insertion forces. The increased needle velocity from oscillation results in decreased tissue deformation, energy absorbed, penetration force, and tissue damage. These effects are partly due to the viscoelastic properties of the biological tissue and can be understood through a modified non-linear Kelvin model that captures the force-deformation response of soft tissue. Since internal tissue deformation for viscoelastic bodies is dependent on velocity, increasing the needle insertion speed results in less tissue deformation. The reduced tissue deformation prior to crack extension increases the rate at which energy is released from the crack, and ultimately reduces the force of rupture. The reduction in force and tissue deformation from the increased rate of needle insertion is especially significant in tissues with high water content such as soft tissue. In addition to reducing the forces associated with cutting into tissue, research has also shown that needle oscillation during insertion reduces the frictional forces between the needle and surrounding tissues.
Recently, a number of vibration devices have been marketed that make use of the Gate's Control Theory of Pain. The basic idea is that the neural processing, and therefore perception of pain, can be minimized or eliminated by competing tactile sensations near the area of pain (or potential pain) originates. Vibrational devices may be placed on the skin in attempt to provide “vibrational anesthesia” to an area prior to, or possibly during, a needle insertion event. Research has shown that tissue penetration with lower insertion forces results in reduced pain. The Gate Control Theory of Pain provides theoretical support for the anesthetic effect of vibration. The needle vibration may stimulate non-nociceptive Aβ fibers and inhibit perception of pain and alleviate the sensation of pain at the spinal cord level. In nature, a mosquito vibrates it's proboscis at a frequency of 17-400 Hz to reduce pain and improve tissue penetration.
Other vibrating devices directly attach to a needle-carrying syringe and employ non-directional vibration of the needle during insertion. Reports suggest that this type of approach can ease the pain of needle insertion for administering local anesthetic during dental procedures, and to enhance the treatment of patients undergoing sclerotherapy. These non-directed vibration techniques do not allow for precise direct control of the needle tip displacements, and by their nature induce vibrations out of the plane of insertion, which could increase the risk for tissue damage during insertion. Furthermore, existing vibrational devices for improving needle insertion cannot be readily integrated into a control system which would allow for the ability to control and/or maintain the magnitude of needle oscillation during insertion through a wide range of tissue types.
A need exists to improve the insertion of penetrating members (such as needles or lancets), by reducing the force required to insert them, causing less tissue deformation, and inducing less pain and stress to the patient, research subject, and clinician/researcher. As such, there remains room for variation and improvement within the art.
Various features and advantages of the invention will be set forth in part in the following description, or may be obvious from the description, or may be learned from practice of the invention.
The invention provides in one exemplary embodiment a handheld device that provides axially-directed oscillatory motion (also referred to as reciprocating motion) to a detachable penetrating member (such as but not limited to lancets, needles, epidural catheters, biopsy instruments, and vascular entry instruments) at a distal end, for use in procedures (such as but not limited to vascular entry, catheterization, and blood collection). The device comprises at least one linear reciprocating actuator that can be reversibly attached to a penetrating member or other composite system which itself contains a penetrating member, and wherein the driving actuator provides motion to the penetrating member, causing it to reciprocate at small displacements, thereby reducing the force required to penetrate through tissues. Reciprocating motion of the penetrating member facilitates less tissue displacement and drag, enabling, for example, easier access into rolling or collapsed vasculature. Specific applications of the invention include, but are not limited to, penetration of tissues for delivery or removal of bodily fluids, tissues, nutrients, medicines, therapies, and placement or removal of catheters. This device is for inserting penetrating members into the body, including human or animal subjects, for a variety of applications.
The handheld device disclosed may be a driving actuator composed of a handpiece body housing at least one oscillatory linear actuator. The actuator is preferably a voice coil motor (VCM) but may alternatively be implemented with a DC motor, solenoid, piezoelectric actuator, or linear vibration motor disposed within the handpiece body. The linear actuator causes a motor shaft to oscillate or vibrate back and forth relative to the handpiece body, in the axial direction of the shaft. Attached to one end of the shaft is a coupling mechanism which enables reversible attachment of a penetrating member (or to a separate device that already has a penetrating member attached to it).
The need for reversible attachment to a range of penetrating members or separate devices that employ a penetrating member, requires a number of different attachment schemes in order to cause linear, reciprocating motion of the penetrating member. In the preferred embodiment the handheld device has a coupler that enables reversible attachment of LUER-Slip® (slip tip) or LUER-Lok® (LUER-Lock) style needle or lancet hubs. In another embodiment of the device, a custom connection enables reversible attachment of separate devices with a penetrating member (such as syringe with attached needle or a safety IV-access device) which allows the linear actuator to vibrate the composite system, thereby resulting in reciprocating motion being delivered to the attached penetrating member.
Additional features include embodiments that enable delivery or removal of fluids down the lumen of hollow penetrating members, via side port that allows access to the inner lumen. Tubing that is sufficiently compliant so as not to impede the reciprocating motion of the actuator and penetrating member, is then used to channel fluid from a source, such as a syringe, into the lumen for delivery of medication or other treatments. The side port which accesses the inner lumen of the penetrating member may also enable bodily fluids or tissues to be extracted by applying suction.
Other additional features include embodiments that enable delivery or removal of fluids through a side mounted syringe that oscillates back and forth relative to the handpiece body where the driving actuator is coupled to the syringe and supplies the oscillation or vibration to the syringe. A coupling mechanism is attached to the syringe that enables reversible attachment of a penetrating member (or to a separate device that already has a penetrating member attached to it). This embodiment includes a means to easily accomplish movement of the syringe plunger to a forward or backward position for delivery or removal of bodily fluids, tissues, nutrients, medicines, or therapies.
With regard to driving actuators in the handpiece that exhibit resonant behavior, such as the VCM actuator (discussed in embodiments presented below), the invention includes a set of methods by which to optimally operate the device in order to achieve desired oscillation amplitudes throughout the insertion of a penetrating member into target tissues. The resonant peak in the displacement versus frequency response of the driving actuator is influenced greatly by the loading from the tissue that interacts with the penetrating member. The reason for the change in the frequency response is because the penetrating member experiences frictional, inertial, and elastic forces that interact with the driving actuator, and the overall system exhibits an altered frequency response. By operating the device at some frequency above the resonant frequency of the driving actuator in air (for example >⅓ octave, but more optimally near ½ octave), the reciprocating motion can be maintained with very little, if any, damping for penetration of many tissue types.
Alternatively a feedback loop can be constructed by employing a displacement sensor (such as, but not limited to, a linear variable differential transformer (LVDT) to continually monitor displacement and a controller that can continually adjust the operating frequency to keep it near the actual resonance frequency of the coupled system (tissue and driving actuator, coupled via penetrating member). By attempting to keep the operating frequency near resonance of the coupled system, power requirements of the device are greatly reduced. Keeping the system at resonance also mitigates the need to ‘overdrive’ the system, i.e., drive at a displacement or frequency greater than needed initially, which can contribute to unnecessary heating. The monitoring of the frequency and displacement of the system can also be used to signal the transducer to stop vibration when penetration of the desired tissue is complete.
Another feedback-based method of maintaining near constant oscillatory displacement amplitude during insertion of the penetrating member into variety of tissues, utilizes current control. With this method, the current amplitude supplied to the driving actuator is increased to overcome the damping effects of tissue on the reciprocating penetration member. Again, a displacement sensor can be employed to continually monitor displacement and adjust current amplitude to achieve the target displacement magnitude. Additional methods may deploy a combination of frequency and current control methods by which to maintain displacement. Other methods may not employ feedback but simply anticipate the loading effect of the target tissue and set the operating frequency or current such that optimal displacement amplitude is achieved at some point during the course of tissue penetration. The system may be off resonance when no load is encountered by the penetrating member. However, when the penetrating member penetrates tissue the loading causes the resonance of the system to move closer to the driving frequency such that no adjustments to the driving actuator are needed. In some instances the resonance of the system may be at the driving frequency in the loaded condition. In other arrangements, the driving actuator may be adjusted so that it is on resonance when in a loaded state, and is off resonance during no load conditions. In yet other arrangements, the operating frequency is not at a resonance frequency when in the no load condition, but the operating frequency is closer to the resonance frequency, as compared to the no load resonance frequency, when in the load condition.
The handheld device of the present invention may require an electrical power signal to excite an internal actuator. Upon excitation by the electrical signal, the driving actuator converts the signal into mechanical energy that results in oscillating motion of the penetrating member, such as an attached needle, lancet, epidural catheter, biopsy instrument, or vascular entry instrument.
Additionally the invention with specific control electronics will provide reduction of force as the penetrating member is inserted and/or retracted from the body.
These and other features, aspects and advantages of the present invention will become better understood with reference to the following description and appended claims. The accompanying drawings, which are incorporated in and constitute part of this specification, illustrate embodiments of the invention and, together with the description, serve to explain the principles of the invention.
A full and enabling disclosure of the present invention, including the best mode thereof, directed to one of ordinary skill in the art, is set forth more particularly in the remainder of the specification, which makes reference to the appended Figs. in which:
Repeat use of reference characters in the present specification and drawings is intended to represent the same or analogous features or elements of the invention.
Reference will now be made in detail to embodiments of the invention, one or more examples of which are illustrated in the drawings. Each example is provided by way of explanation of the invention, and not meant as a limitation of the invention. For example, features illustrated or described as part of one embodiment can be used with another embodiment to yield still a third embodiment. It is intended that the present invention include these and other modifications and variations.
It is to be understood that the ranges mentioned herein include all ranges located within the prescribed range. As such, all ranges mentioned herein include all sub-ranges included in the mentioned ranges. For instance, a range from 100-200 also includes ranges from 110-150, 170-190, and 153-162. Further, all limits mentioned herein include all other limits included in the mentioned limits. For instance, a limit of up to 7 also includes a limit of up to 5, up to 3, and up to 4.5.
The preferred embodiments of the present invention are illustrated in
The effectiveness of the invention as described, utilizes high-speed oscillatory motion to reduce forces associated with inserting a penetrating member through tissue or materials found within the body. Essentially, when tissue is penetrated by a high speed operation of a penetrating member portion of the device, such as a needle, the force required for entry as well as the amount of tissue deformation is reduced. A reciprocating penetrating member takes advantage of properties of high speed needle insertion, but because the displacement during each oscillatory cycle is small (typically <1 mm) it still enables the ability to maneuver or control the needle, such as to follow a non-linear insertion path or to manual advance the needle to a precise target.
To exploit the reduction of force effect, the medical device of the present invention is designed such that the penetrating distal tip portion attains a short travel distance or displacement at high speed, axially reciprocating at a specified frequency. Utilizing the various device configurations as described in the aforementioned embodiments, it has been determined that the reciprocating motion of the penetrating member may include a displacement for the motor shaft of the driving actuator between 0.1-2 mm, more preferably between 0.5-1.5 mm, at a frequency of between 50-500 Hz, but most preferably at 75-200 Hz for insertion into soft tissues within the body. This motion is caused by the penetrating member 10 being attached to a voice coil motor operated with an AC power signal.
Generally, any type of motor comprising an actuator assembly, further comprising a voice coil motor (VCM), or solenoid, or any other translational motion device, including piezoelectric actuators, would serve as a driving actuator and also fall within the spirit and scope of the invention.
Referring again to
Feedback means via LVDT 69 and LVDT core 70 can be implemented to monitor oscillatory displacement magnitude, oscillatory frequency, and displacement magnitude from center position. Oscillatory displacement magnitude can be utilized as electromechanical feedback for ensuring the motor shaft 5 is displacing optimally and also potentially can provide a signal that triggers an auto-shut of mechanism. Additionally the LVDT 69 and LVDT core 70 can be used as a force sensor by monitoring the oscillatory center position and comparing it to the unloaded center position. The displacement from center position can be calibrated to relate to a force, since the restoring force provided by the centering magnets 3 increases in proportion to the displacement. This information can be relayed to the operator and/or used as an operating state change trigger.
In some embodiments where larger displacements are desired or a lower resonant frequency is needed, the function of the centering magnets 3 may be replaced with springs, elastic material, and may include a means to dynamically modulate the stiffness of the restoring force or to implement non-symmetric centering forces so that when the penetrating member experiences force from the tissue, the magnet assembly 4 would be located more centrally within the VCM body 8.
One aspect of performing procedures correctly is a manner in which to hold the bevel end (12 in
In another embodiment as shown in
To ensure that the oscillatory motion is not over damped by the coupling sled 22, the moving mechanism must have sufficiently small resistance coefficient. In one embodiment the coupling sled is guided solely by the shape of the handpiece body (1b in
Another method of counteracting the oscillatory damping that is caused by the axial force applied to the penetrating member by the tissue is to employ feedback to adjust the operating frequency or current during the penetration. Two different approaches are now mentioned and illustrated with the aid of
In
Additional means for maintaining oscillatory displacement level could employ a combination of frequency and current control.
In the preferred embodiment of the VCM-based driving actuator 1, the VCM coil 2 may be driven by control circuitry such that a constant supply voltage can be applied to the VCM coil 2 at both positive and negative potential or can be turned off to apply zero volts. This supply voltage is switched on and off at a frequency between 10 kHz and 40 kHz where the time that the supply voltage is either ‘on’ or ‘off’ can be adjusted. The average voltage seen by the VCM coil 2 over a given switching cycle is proportional to the time the supply voltage is applied. For example, if the supply voltage is applied for 50% of the switching cycle the average voltage seen by the VCM coil 2 will be 50% of the supply voltage. When the VCM coil 2 is supplied with a positive potential voltage a force proportional to the applied voltage will be applied to the magnet assembly 4 of the VCM in one direction while a negative potential voltage will apply a force to the magnet assembly 4 in the opposite direction. By periodically reversing the polarity of the applied potential of the switching signal at 50-500 Hz, an oscillating force can be applied to the motor shaft 5 by way of the attached magnet assembly 4 with an average magnitude proportional to the average voltage magnitude of the generated signal. The energy of this signal will be located at the frequency at which the potential is reversed and every odd multiple of this frequency, the magnitude of which will decrease with each increasing multiple. Likewise, additional energy will also be located at the switching frequency and every odd multiple of this frequency, the magnitude of which will decrease with each increasing multiple.
The frequency response seen in
Now that exemplary embodiments of the present invention have been shown and described in detail, various modifications and improvements thereon will become apparent. While the foregoing embodiments may have dealt with the penetration through skin, bone, veins and ligaments as exemplary biological tissues, the present invention can undoubtedly ensure similar effects with other tissues which are commonly penetrated within the body. For example there are multiplicities of other tools like central venous catheter introducers, laparoscopic instruments with associated sharps, cavity drainage catheter kits, and neonatal lancets, as well as procedures like insulin administration and percutaneous glucose testing, to name a few, where embodiments disclosed herein comprising sonically or ultrasonically driven sharps members may be used to precisely pierce or puncture tissues with minimal tinting.
While the present invention has been described in connection with certain preferred embodiments, it is to be understood that the subject matter encompassed by way of the present invention is not to be limited to those specific embodiments. On the contrary, it is intended for the subject matter of the invention to include all alternatives, modifications and equivalents as can be included within the spirit and scope of the following claims.
This application claims the benefit under 35 U.S.C § 119(e) of U.S. Provisional Application Ser. No. 61/895,789 filed on Oct. 25, 2013 and entitled, “DEVICE AND METHOD FOR LESS FORCEFUL TISSUE PUNCTURE.” U.S. Provisional Application Ser. No. 61/895,789 is incorporated by reference herein in its entirety for all purposes. This application is also a continuation-in-part application and claims the benefit under 35 U.S.C. § 120 of U.S. application Ser. No. 14/329,177, filed on Jul. 11, 2014, entitled Medical Tool for Reduced Penetration Force with Feedback Means. U.S. application Ser. No. 14/329,117 is incorporated by reference herein in its entirety for all purposes. U.S. application Ser. No. 14/329,117 is a continuation application and claims the benefit under 35 U.S.C. § 120 of U.S. application Ser. No. 13/672,482, filed on Nov. 8, 2012, entitled MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS, which issued as U.S. Pat. No. 8,777,871 on Jul. 15, 2014. U.S. application Ser. No. 13/672,482 is a continuation application that claims the benefit under 35 U.S.C. § 120 of U.S. application Ser. No. 12/559,383, filed on Sep. 14, 2009, entitled MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS, which issued as U.S. Pat. No. 8,328,738 on Dec. 11, 2012 which claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application Ser. No. 61/089,756 filed on Sep. 15, 2008 entitled MEDICAL TOOL FOR REDUCED PENETRATION FORCE WITH FEEDBACK MEANS, and also is a continuation-in-part application and claims the benefit under 35 U.S.C. § 120 of U.S. application Ser. No. 12/163,071 filed on Jun. 27, 2008 entitled MEDICAL TOOL FOR REDUCED PENETRATION FORCE, which issued as U.S. Pat. No. 8,043,229 on Oct. 25, 2011, which in turn claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application Ser. No. 60/937,749 filed on Jun. 29, 2007 entitled RESONANCE DRIVEN VASCULAR ENTRY NEEDLE and all of whose entire disclosures are incorporated by reference herein in their entireties for all purposes.
This invention was made with government support under RR024943 and AG037214 awarded by the National Institutes of Health, and 2013-33610-20821 awarded by the USDA. The government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
4428748 | Peyman | Jan 1984 | A |
4553541 | Burns | Nov 1985 | A |
4623335 | Jackson | Nov 1986 | A |
4648406 | Miller | Mar 1987 | A |
4771660 | Yacowitz | Sep 1988 | A |
4801293 | Jackson | Jan 1989 | A |
4911161 | Schechter | Mar 1990 | A |
5024662 | Menes et al. | Jun 1991 | A |
5151083 | Pichler | Sep 1992 | A |
5217478 | Rexroth | Jun 1993 | A |
5221282 | Wuchinich | Jun 1993 | A |
5320613 | Houge | Jun 1994 | A |
5403276 | Schechter | Apr 1995 | A |
5449370 | Vaitekunas | Sep 1995 | A |
5471102 | Becker et al. | Nov 1995 | A |
5526820 | Khoury | Jun 1996 | A |
5575789 | Bell | Nov 1996 | A |
5647851 | Pokras | Jul 1997 | A |
5681283 | Brownfield | Oct 1997 | A |
5711302 | Larnpropoulos | Jan 1998 | A |
5728089 | Lal et al. | Mar 1998 | A |
5728130 | Ishikawa et al. | Mar 1998 | A |
5729077 | Newnham et al. | Mar 1998 | A |
5735813 | Lewis | Apr 1998 | A |
5769086 | Ritchart | Jun 1998 | A |
5840026 | Uber, III et al. | Nov 1998 | A |
5843109 | Mehta | Dec 1998 | A |
5865764 | Moorhead | Feb 1999 | A |
5871470 | McWha | Feb 1999 | A |
5885226 | Rubinstein et al. | Mar 1999 | A |
5954701 | Matalon | Sep 1999 | A |
6019775 | Sakurai | Feb 2000 | A |
6019776 | Preissman et al. | Feb 2000 | A |
6068604 | Krause | May 2000 | A |
6096004 | Meglan et al. | Aug 2000 | A |
6190333 | Valencia | Feb 2001 | B1 |
6245028 | Furst et al. | Jun 2001 | B1 |
6273861 | Bates et al. | Aug 2001 | B1 |
6379371 | Novak et al. | Apr 2002 | B1 |
6402701 | Kaplan | Jun 2002 | B1 |
6423014 | Churchill et al. | Jul 2002 | B1 |
6443910 | Krueger et al. | Sep 2002 | B1 |
6465936 | Knowles et al. | Oct 2002 | B1 |
6402769 | Boukhny | Nov 2002 | B1 |
6491708 | Madan et al. | Dec 2002 | B2 |
6497714 | Ishikawa et al. | Dec 2002 | B1 |
6514267 | Jewett | Feb 2003 | B2 |
6602229 | Coss | Aug 2003 | B2 |
6623429 | Percival | Sep 2003 | B2 |
6629922 | Puria | Oct 2003 | B1 |
6664712 | Rayner | Dec 2003 | B2 |
6673086 | Hofmeier et al. | Jan 2004 | B1 |
6689087 | Pal et al. | Feb 2004 | B2 |
6702761 | Damadian | Mar 2004 | B1 |
6718196 | Mah et al. | Apr 2004 | B1 |
6726698 | Cimino | Apr 2004 | B2 |
6730043 | Krueger et al. | May 2004 | B2 |
6785572 | Yanof et al. | Aug 2004 | B2 |
6817973 | Merril et al. | Nov 2004 | B2 |
6869439 | White et al. | Mar 2005 | B2 |
6939317 | Zacharias | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
6984220 | Wuchinich | Jan 2006 | B2 |
7018343 | Plishka | Mar 2006 | B2 |
7025774 | Freeman et al. | Apr 2006 | B2 |
7206626 | Quaid, III | Apr 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7335997 | Wiener | Feb 2008 | B2 |
7364567 | Beyerlein | Apr 2008 | B2 |
7374544 | Freeman et al. | May 2008 | B2 |
7518479 | Mask et al. | Apr 2009 | B2 |
7585280 | Wilson | Sep 2009 | B2 |
7618409 | Hochman | Nov 2009 | B2 |
7648468 | Boecker et al. | Jan 2010 | B2 |
7651475 | Angel et al. | Jan 2010 | B2 |
7651490 | Boukhny et al. | Jan 2010 | B2 |
7654825 | Ray | Feb 2010 | B2 |
7776027 | Manna et al. | Aug 2010 | B2 |
7896833 | Hochman | Mar 2011 | B2 |
7922689 | Lechner | Apr 2011 | B2 |
7955301 | McKay | Jun 2011 | B1 |
8043308 | Bittenson | Oct 2011 | B2 |
8075496 | Deck | Dec 2011 | B2 |
8142365 | Miller | Mar 2012 | B2 |
8231645 | List | Jul 2012 | B2 |
20010014785 | Sussman et al. | Aug 2001 | A1 |
20020010390 | Guice | Jan 2002 | A1 |
20020026127 | Balbierz et al. | Feb 2002 | A1 |
20020042594 | Lum | Apr 2002 | A1 |
20020049462 | Friedman | Apr 2002 | A1 |
20020077589 | Tessari | Jun 2002 | A1 |
20020109433 | Rayner | Aug 2002 | A1 |
20020183774 | Witt et al. | Dec 2002 | A1 |
20020198555 | White et al. | Dec 2002 | A1 |
20030040737 | Merril | Feb 2003 | A1 |
20030078495 | Goodwin | Apr 2003 | A1 |
20030109871 | Johnson et al. | Jun 2003 | A1 |
20030195468 | Lal et al. | Oct 2003 | A1 |
20030199899 | Boecker et al. | Oct 2003 | A1 |
20030199909 | Boecker | Oct 2003 | A1 |
20040010204 | Weber | Jan 2004 | A1 |
20040010251 | Pitaru | Jan 2004 | A1 |
20040024358 | Meythaler | Feb 2004 | A1 |
20040049216 | Verdaasdonk | Mar 2004 | A1 |
20040082884 | Pal | Apr 2004 | A1 |
20040106894 | Hunter et al. | Jun 2004 | A1 |
20040215080 | Lechner | Oct 2004 | A1 |
20040260240 | Beyerlein | Dec 2004 | A1 |
20050070458 | John | Mar 2005 | A1 |
20050131345 | Miller | Jun 2005 | A1 |
20050148940 | Miller | Jul 2005 | A1 |
20050177201 | Freeman | Aug 2005 | A1 |
20060058783 | Buchman, III | Mar 2006 | A1 |
20060122555 | Hochman | Jun 2006 | A1 |
20060129091 | Bonnette | Jun 2006 | A1 |
20060135882 | Bleich | Jun 2006 | A1 |
20060142657 | Quaid et al. | Jun 2006 | A1 |
20060149141 | Sheets | Jul 2006 | A1 |
20060149161 | Wilson | Jul 2006 | A1 |
20060195043 | Rutherford | Aug 2006 | A1 |
20060224144 | Lee | Oct 2006 | A1 |
20070038129 | Kishimoto | Feb 2007 | A1 |
20070063618 | Bromfield | Mar 2007 | A1 |
20070079455 | Brewer | Apr 2007 | A1 |
20070088297 | Redding | Apr 2007 | A1 |
20070088376 | Zacharias | Apr 2007 | A1 |
20070106158 | Madan | May 2007 | A1 |
20070123888 | Bleich | May 2007 | A1 |
20070129628 | Hirsh | Jun 2007 | A1 |
20070129732 | Zacharias | Jun 2007 | A1 |
20070142766 | Sundar et al. | Jun 2007 | A1 |
20070191758 | Hunter et al. | Aug 2007 | A1 |
20070219496 | Kamen et al. | Sep 2007 | A1 |
20070250113 | Hegeman et al. | Oct 2007 | A1 |
20070255220 | King | Nov 2007 | A1 |
20080021490 | Briggs et al. | Jan 2008 | A1 |
20080055028 | Mask | Mar 2008 | A1 |
20080097287 | Nelson | Apr 2008 | A1 |
20080103413 | Cicenas et al. | May 2008 | A1 |
20080139961 | Slama et al. | Jun 2008 | A1 |
20080147094 | Bittenson | Jun 2008 | A1 |
20080154188 | Hochman | Jun 2008 | A1 |
20080228104 | Uber et al. | Sep 2008 | A1 |
20080255444 | Li | Oct 2008 | A1 |
20090005703 | Fasciano | Jan 2009 | A1 |
20090069712 | Mulvihill et al. | Mar 2009 | A1 |
20090131830 | Freeman | May 2009 | A1 |
20090131832 | Sacristan Rock | May 2009 | A1 |
20090157044 | Liyanagama | Jun 2009 | A1 |
20090204119 | Bleich | Aug 2009 | A1 |
20090240205 | Wen | Sep 2009 | A1 |
20090247865 | Spohn et al. | Oct 2009 | A1 |
20090270759 | Wilson | Oct 2009 | A1 |
20100004558 | Frankhouser | Jan 2010 | A1 |
20100010505 | Herlihy et al. | Jan 2010 | A1 |
20100036245 | Yu et al. | Feb 2010 | A1 |
20100036256 | Boukhny | Feb 2010 | A1 |
20100069828 | Steen | Mar 2010 | A1 |
20100069851 | Vad | Mar 2010 | A1 |
20100094143 | Mahapatra | Apr 2010 | A1 |
20110004159 | Nelson | Jan 2011 | A1 |
20110125107 | Slocum | May 2011 | A1 |
20110130758 | Bleich | Jun 2011 | A9 |
20110224623 | Velez Rivera | Sep 2011 | A1 |
20110298628 | Vad | Dec 2011 | A1 |
20120078231 | Hoshinouchi | Mar 2012 | A1 |
20120210569 | Schmitt | Aug 2012 | A1 |
20120220942 | Hall | Aug 2012 | A1 |
20120232488 | Aviles | Sep 2012 | A1 |
20130072856 | Frankhouser et al. | Mar 2013 | A1 |
20140142553 | Poncon | May 2014 | A1 |
20140299568 | Browne | Oct 2014 | A1 |
20150182232 | Peterson | Jul 2015 | A1 |
20150283334 | Marx et al. | Oct 2015 | A1 |
20150297404 | Kang | Oct 2015 | A1 |
20150297449 | Browne | Oct 2015 | A1 |
20150306358 | Duffy | Oct 2015 | A1 |
Number | Date | Country |
---|---|---|
0266058 | May 1988 | EP |
1647255 | Apr 2006 | EP |
9239031 | Sep 1997 | JP |
2001346874 | Dec 2001 | JP |
2004091693 | Oct 2004 | WO |
2008086560 | Jul 2008 | WO |
2008097609 | Aug 2008 | WO |
2009083600 | Jul 2009 | WO |
2009092164 | Jul 2009 | WO |
2009097621 | Aug 2009 | WO |
Entry |
---|
United States Patent and Trademark Office; Office Action; Office Action from U.S. Appl. No. 15/205,357; pp. 1-16; publisher United States Patent and Trademark Office; published Alexandria, Virginia, USA; copyright and dated Dec. 23, 2016; (16 pages). |
International Searching Authority; International Search Report and Written Opinion of the International Searching Authority; International Application No. PCT/US2014/062099; Patent Cooperation Treaty; pp. 1-10; publisher United States Intearnatinal Searching Authority; Published Alexandria, Virginia, US; copyright and dated Mar. 11, 2015; (10 pages). |
Meyer Jr., R.J., et al., “Displacement Amplification of Electroactive Materials Using the Cymbal Flextensional Transducer”, Sensors and Actuators A 87 (2001) 157-162. |
Podder, T.K., et al., “Effects of Velocity Modulation During Surgical Needle Insertion”, Proceedings of the 2005 IEEE, Engineering in Medicine and Biology 27th Annual Conference, Sep. 1-4, 2005. |
Luis, J., et al., “Rectangular Cymbal Arrays for Improved Ultrasonic Transdermal Insulin Delivery”, J. Acoust. Soc. Am., vol. 122, Issue 4, Oct. 2007. |
Yang, M., et al., “Microneedle Insertion Force Reduction Using Vibratory Actuation”, Biomedical Microdevices 6:3, 177-182, 2004. |
Zorcolo, et al., “Catheter Insertion Simulation With Combined Visual and Haptic Feedback”, Center for Advanced Studies, Research and Development in Sardinia 09101 Uta (CA) Italy. |
Piccin, et al., “A Robotized Needle Insertion Device for Percutaneous Procedures”, Proceedings of IDETC/CIE 2005, 2006 ASME International Design Engineering Technical Conferences and Computers and Information in Engineering Conference, Long Beach, CA, USA, Sep. 24-28, 2005. |
Loeffel, et al., “Development of an Advanced Injection Device for Highly Viscous Materials”, European Cells and Materials, vol. 11, Supp. 1, 2006, p. 51. |
Dario, et al., “Small Surgical Tools and Augmenting Devices”, IEEE Transactions on Robotics and Automation, vol. 19, No. 5, Oct. 2003, pp. 782-792. |
“Sonic Drill Could Go Into Space”, R&D, Sep. 2000, p. 135. |
Goethals, P., “Tactile Feedback for Robot Assisted Minimally Invasive Surgery: An Overview”, Division PMA, Department of Engineering, K.U. Leuven, Jul. 14, 2008. |
Zorcolo, et al., “Catheter Insertion Simulation with Combined Visual and Haptic Feedback”, Center for Advanced Studies, Research and Development in Sardinia, 09101 Uta (CA) Italy; Proceedings of the First PHANToM Users Research Symposium, May 21-22, 1999, Deutsches Krebsfordschungszentrum, Heidelberg, Germany. |
“Mark V ProVis Angiographic Injection System”, Medrad, Inc., Copyright 2006-2010. |
Kwon, et al., “Realistic Force Reflection in the Spine Biopsy Simulator”, IEEE International Conference on Robotics and Automation, 2001. Proceedings 2001 ICRA, May 21-26, 2001, Seoul, Korea 2001, vol. 2, 1358-1363. |
“R&D 100 Awards Winners Reveal 21st Century Technologies”, 38th Annual R&D Awards, R&D Research & Development, Sep. 2000, p. 135. |
“Silicon-Based Ultrasonic Surgical Actuators”, Amit Lal, Member, IEEE; Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 20, No. 6, 1998, pp. 2785-2790. |
Terrett, et al., “3538 Study Assessing the Effectiveness of a Vibrating Dental Syringe Attachment”, Pain Management, Oral Pathology, Malodor, and Indices, Mar. 13, 2004. |
Lal, “Silicon-Based Ultrasonic Surgical Actuators”, Proceedings of the 20th Annual Conference of the IEEE in Medicine and Biology Society, vol. 20, No. 6, 1998, pp. 2785-2790. |
Hing, et al., Reality-Based Needle Insertion Simulation for Haptic Feedback in Prostate Brachytherapy, Proceedings of the 2006 IEEE International Conference on Robotics and Automation, Orlando, Florida, May 2006. |
Hing, et al., “Reality-Based Estimation of Needle and Soft-Tissue Interaction for Accurate Haptic Feedback in Prostate Brachytherapy Simulation”, Program for Robotics, Intelligent Sensing, and Mechatronics (PRISM) Laboratory, Drexel University, Philadelphia, PA, Drexel University College of Medicine, Philadelphia, PA. |
International Preliminary Report on Patentability for PCT Application No. PCT/AU2008/000019, dated Jul. 21, 2009. |
International Search Report for PCT Application No. PCT/US2009/060387, dated May 18, 2010. |
International Search Report for PCT Application No. PCT/US2009/056864, dated Apr. 26, 2010. |
United States Patent and Trademark Office; Office Action; Office Action from U.S. Appl. No. 13/222,363;copyright and dated Dec. 11, 2014; pp. 1-9; publisher United States Patent and Trademark Office; Published Alexandria, Virginia, USA; copyright and dated Dec. 11, 2014; (9 pages). |
United States Patent and Trademark Office; Office Action; Office Action from U.S. Appl. No. 14/329,177; copyright and dated Nov. 18, 2014; pp. 1-19; publisher United States Patent and Trademark Office; Published Alexandria, Virginia, USA; copyright and dated Nov. 18, 2014; (19 pages). |
United States Patent and Trademark Office; Office Action; Office Action from U.S. Appl. No. 15/205,357; pp. 1-48; publisher United States Patent and Trademark Office; published Alexandria, Virginia, USA; copyright and dated Jun. 22, 2017; (48 pages). |
Number | Date | Country | |
---|---|---|---|
20150073357 A1 | Mar 2015 | US |
Number | Date | Country | |
---|---|---|---|
61895789 | Oct 2013 | US | |
61089756 | Sep 2008 | US | |
60937749 | Jun 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13672482 | Nov 2012 | US |
Child | 14329177 | US | |
Parent | 12559383 | Sep 2009 | US |
Child | 13672482 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14329177 | Jul 2014 | US |
Child | 14522681 | US | |
Parent | 12163071 | Jun 2008 | US |
Child | 12559383 | US |